nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—nipple—breast cancer	0.0121	0.153	CbGeAlD
Pamidronate—FDPS—skin of body—breast cancer	0.00778	0.0982	CbGeAlD
Pamidronate—FDPS—endometrium—breast cancer	0.00733	0.0926	CbGeAlD
Pamidronate—FDPS—uterus—breast cancer	0.00676	0.0853	CbGeAlD
Pamidronate—FDPS—pituitary gland—breast cancer	0.00664	0.0838	CbGeAlD
Pamidronate—FDPS—adipose tissue—breast cancer	0.00661	0.0834	CbGeAlD
Pamidronate—FDPS—female reproductive system—breast cancer	0.00608	0.0767	CbGeAlD
Pamidronate—FDPS—adrenal gland—breast cancer	0.00593	0.0748	CbGeAlD
Pamidronate—FDPS—bone marrow—breast cancer	0.00574	0.0724	CbGeAlD
Pamidronate—FDPS—female gonad—breast cancer	0.00553	0.0698	CbGeAlD
Pamidronate—FDPS—endocrine gland—breast cancer	0.00514	0.0649	CbGeAlD
Pamidronate—Zoledronate—ABCC1—breast cancer	0.00395	0.433	CrCbGaD
Pamidronate—FDPS—lymph node—breast cancer	0.00355	0.0449	CbGeAlD
Pamidronate—FDPS—SREBP signalling—PPARGC1B—breast cancer	0.00245	0.0567	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA2—breast cancer	0.00233	0.0538	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—FASN—breast cancer	0.00226	0.0522	CbGpPWpGaD
Pamidronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA1—breast cancer	0.00196	0.0453	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA2—breast cancer	0.00186	0.043	CbGpPWpGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—FASN—breast cancer	0.0018	0.0417	CbGpPWpGaD
Pamidronate—Risedronate—PTGS2—breast cancer	0.00158	0.173	CrCbGaD
Pamidronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA1—breast cancer	0.00156	0.0362	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—FASN—breast cancer	0.00146	0.0337	CbGpPWpGaD
Pamidronate—Clodronate—PTGS2—breast cancer	0.00141	0.154	CrCbGaD
Pamidronate—Histamine Phosphate—CYP2D6—breast cancer	0.00118	0.129	CrCbGaD
Pamidronate—FDPS—SREBP signalling—SIRT1—breast cancer	0.00111	0.0256	CbGpPWpGaD
Pamidronate—Histamine Phosphate—CYP3A4—breast cancer	0.00101	0.11	CrCbGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	0.000875	0.0203	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.000639	0.0148	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—MTOR—breast cancer	0.000604	0.014	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.00058	0.0134	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.00058	0.0134	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.00055	0.0127	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.000503	0.0116	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.000467	0.0108	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.000453	0.0105	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.000417	0.00964	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.000412	0.00952	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—IDH1—breast cancer	0.000402	0.0093	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SYNJ2—breast cancer	0.00039	0.00902	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—PIK3CA—breast cancer	0.000368	0.00852	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NDUFS3—breast cancer	0.000362	0.00839	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—MED12—breast cancer	0.000349	0.00807	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CHST9—breast cancer	0.000341	0.00789	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	0.000333	0.00771	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	0.000324	0.0075	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—COX11—breast cancer	0.000323	0.00748	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	0.000318	0.00735	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—breast cancer	0.000308	0.00713	CbGpPWpGaD
Pamidronate—FDPS—SREBP signalling—AKT1—breast cancer	0.000301	0.00696	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CDA—breast cancer	0.000295	0.00684	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SHMT1—breast cancer	0.000295	0.00684	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	0.000292	0.00675	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	0.000289	0.00668	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SLC2A5—breast cancer	0.000284	0.00658	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SLCO1B1—breast cancer	0.000284	0.00658	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	0.000278	0.00643	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—APRT—breast cancer	0.000275	0.00636	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—FASN—breast cancer	0.00027	0.00624	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—breast cancer	0.000268	0.00621	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ESRRA—breast cancer	0.000258	0.00598	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ANGPTL4—breast cancer	0.000258	0.00598	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	0.000246	0.00568	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GPI—breast cancer	0.000245	0.00567	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HADHB—breast cancer	0.000245	0.00567	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	0.000234	0.00542	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALDH7A1—breast cancer	0.000234	0.0054	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALDH1A1—breast cancer	0.000234	0.0054	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	0.000231	0.00534	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ADSL—breast cancer	0.000224	0.00518	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PHGDH—breast cancer	0.000224	0.00518	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—UMPS—breast cancer	0.000224	0.00518	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NME1—breast cancer	0.000224	0.00518	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—FHL2—breast cancer	0.000224	0.00518	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HPSE—breast cancer	0.00022	0.00508	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—BRIP1—breast cancer	0.00022	0.00508	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—LDHB—breast cancer	0.00022	0.00508	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA3—breast cancer	0.000208	0.00482	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—HMMR—breast cancer	0.000208	0.00482	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ABCC1—breast cancer	0.000208	0.00482	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PPARGC1B—breast cancer	0.000202	0.00467	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	0.000196	0.00454	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	0.000196	0.00454	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CA9—breast cancer	0.00019	0.00441	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA4—breast cancer	0.00019	0.00441	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—breast cancer	0.000188	0.00435	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	0.000186	0.00431	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA2—breast cancer	0.000186	0.00429	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GPX2—breast cancer	0.000186	0.00429	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GPX4—breast cancer	0.000183	0.00424	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—SULT1A1—breast cancer	0.000183	0.00424	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—IDH1—breast cancer	0.000179	0.00414	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—GSTA1—breast cancer	0.000179	0.00414	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NAT2—breast cancer	0.000177	0.0041	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.00016	0.0037	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MED12—breast cancer	0.000155	0.00359	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—DPYD—breast cancer	0.000155	0.00359	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALDOA—breast cancer	0.000153	0.00354	CbGpPWpGaD
Pamidronate—Alopecia—Methotrexate—breast cancer	0.000153	0.000176	CcSEcCtD
Pamidronate—Vomiting—Gemcitabine—breast cancer	0.000153	0.000176	CcSEcCtD
Pamidronate—Dyspnoea—Docetaxel—breast cancer	0.000152	0.000175	CcSEcCtD
Pamidronate—Somnolence—Docetaxel—breast cancer	0.000151	0.000174	CcSEcCtD
Pamidronate—Rash—Gemcitabine—breast cancer	0.000151	0.000174	CcSEcCtD
Pamidronate—Dermatitis—Gemcitabine—breast cancer	0.000151	0.000174	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—breast cancer	0.000151	0.000174	CcSEcCtD
Pamidronate—Erythema—Methotrexate—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Headache—Gemcitabine—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Capecitabine—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Flushing—Epirubicin—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Vomiting—Fluorouracil—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Dyspepsia—Docetaxel—breast cancer	0.00015	0.000173	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—breast cancer	0.00015	0.000172	CcSEcCtD
Pamidronate—Insomnia—Capecitabine—breast cancer	0.000149	0.000172	CcSEcCtD
Pamidronate—Rash—Fluorouracil—breast cancer	0.000149	0.000171	CcSEcCtD
Pamidronate—Dermatitis—Fluorouracil—breast cancer	0.000149	0.000171	CcSEcCtD
Pamidronate—FDPS—Metabolism—NCOA3—breast cancer	0.000148	0.00343	CbGpPWpGaD
Pamidronate—Paraesthesia—Capecitabine—breast cancer	0.000148	0.00017	CcSEcCtD
Pamidronate—Decreased appetite—Docetaxel—breast cancer	0.000148	0.00017	CcSEcCtD
Pamidronate—Hypersensitivity—Paclitaxel—breast cancer	0.000148	0.00017	CcSEcCtD
Pamidronate—Headache—Fluorouracil—breast cancer	0.000148	0.00017	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—breast cancer	0.000148	0.00017	CcSEcCtD
Pamidronate—FDPS—Metabolism—SLC2A2—breast cancer	0.000147	0.00341	CbGpPWpGaD
Pamidronate—Dysgeusia—Methotrexate—breast cancer	0.000147	0.00017	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Docetaxel—breast cancer	0.000147	0.000169	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—breast cancer	0.000147	0.000169	CcSEcCtD
Pamidronate—Dyspnoea—Capecitabine—breast cancer	0.000147	0.000169	CcSEcCtD
Pamidronate—Fatigue—Docetaxel—breast cancer	0.000147	0.000169	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—breast cancer	0.000147	0.000169	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—breast cancer	0.000147	0.000169	CcSEcCtD
Pamidronate—Nausea—Irinotecan—breast cancer	0.000146	0.000168	CcSEcCtD
Pamidronate—Nausea—Mitoxantrone—breast cancer	0.000146	0.000168	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—breast cancer	0.000146	0.000168	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000146	0.00337	CbGpPWpGaD
Pamidronate—Mediastinal disorder—Epirubicin—breast cancer	0.000146	0.000168	CcSEcCtD
Pamidronate—Pain—Docetaxel—breast cancer	0.000146	0.000168	CcSEcCtD
Pamidronate—Constipation—Docetaxel—breast cancer	0.000146	0.000168	CcSEcCtD
Pamidronate—Back pain—Methotrexate—breast cancer	0.000145	0.000167	CcSEcCtD
Pamidronate—Dyspepsia—Capecitabine—breast cancer	0.000145	0.000167	CcSEcCtD
Pamidronate—Chills—Epirubicin—breast cancer	0.000145	0.000167	CcSEcCtD
Pamidronate—FDPS—Metabolism—ABCG2—breast cancer	0.000144	0.00334	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CPT1A—breast cancer	0.000144	0.00334	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—MTR—breast cancer	0.000144	0.00334	CbGpPWpGaD
Pamidronate—Asthenia—Paclitaxel—breast cancer	0.000144	0.000166	CcSEcCtD
Pamidronate—Decreased appetite—Capecitabine—breast cancer	0.000143	0.000165	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—breast cancer	0.000143	0.000164	CcSEcCtD
Pamidronate—Nausea—Gemcitabine—breast cancer	0.000143	0.000164	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Capecitabine—breast cancer	0.000142	0.000164	CcSEcCtD
Pamidronate—Fatigue—Capecitabine—breast cancer	0.000142	0.000164	CcSEcCtD
Pamidronate—Pruritus—Paclitaxel—breast cancer	0.000142	0.000164	CcSEcCtD
Pamidronate—FDPS—Metabolism—HPGDS—breast cancer	0.000142	0.00327	CbGpPWpGaD
Pamidronate—Pain—Capecitabine—breast cancer	0.000141	0.000162	CcSEcCtD
Pamidronate—Constipation—Capecitabine—breast cancer	0.000141	0.000162	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—breast cancer	0.000141	0.000162	CcSEcCtD
Pamidronate—Erythema—Epirubicin—breast cancer	0.000141	0.000162	CcSEcCtD
Pamidronate—FDPS—Metabolism—HBA1—breast cancer	0.000141	0.00325	CbGpPWpGaD
Pamidronate—Feeling abnormal—Docetaxel—breast cancer	0.00014	0.000162	CcSEcCtD
Pamidronate—Nausea—Fluorouracil—breast cancer	0.00014	0.000161	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—breast cancer	0.00014	0.000161	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—breast cancer	0.00014	0.000161	CcSEcCtD
Pamidronate—Gastrointestinal pain—Docetaxel—breast cancer	0.000139	0.00016	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—breast cancer	0.000139	0.00016	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—breast cancer	0.000139	0.00016	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—breast cancer	0.000139	0.00016	CcSEcCtD
Pamidronate—Tension—Epirubicin—breast cancer	0.000138	0.000159	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—breast cancer	0.000138	0.000159	CcSEcCtD
Pamidronate—Diarrhoea—Paclitaxel—breast cancer	0.000137	0.000158	CcSEcCtD
Pamidronate—FDPS—Metabolism—GSTT1—breast cancer	0.000137	0.00318	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ACHE—breast cancer	0.000137	0.00318	CbGpPWpGaD
Pamidronate—Nervousness—Epirubicin—breast cancer	0.000137	0.000157	CcSEcCtD
Pamidronate—Back pain—Epirubicin—breast cancer	0.000136	0.000157	CcSEcCtD
Pamidronate—Feeling abnormal—Capecitabine—breast cancer	0.000136	0.000156	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—breast cancer	0.000136	0.000156	CcSEcCtD
Pamidronate—Malaise—Methotrexate—breast cancer	0.000136	0.000156	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—breast cancer	0.000135	0.000156	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—breast cancer	0.000135	0.000156	CcSEcCtD
Pamidronate—Gastrointestinal pain—Capecitabine—breast cancer	0.000135	0.000155	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—breast cancer	0.000135	0.000155	CcSEcCtD
Pamidronate—Body temperature increased—Docetaxel—breast cancer	0.000135	0.000155	CcSEcCtD
Pamidronate—Abdominal pain—Docetaxel—breast cancer	0.000135	0.000155	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—breast cancer	0.000135	0.000155	CcSEcCtD
Pamidronate—Chills—Doxorubicin—breast cancer	0.000134	0.000155	CcSEcCtD
Pamidronate—Dizziness—Paclitaxel—breast cancer	0.000133	0.000153	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—breast cancer	0.000132	0.000152	CcSEcCtD
Pamidronate—Cough—Methotrexate—breast cancer	0.000131	0.000151	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—breast cancer	0.000131	0.00015	CcSEcCtD
Pamidronate—Body temperature increased—Capecitabine—breast cancer	0.00013	0.00015	CcSEcCtD
Pamidronate—Abdominal pain—Capecitabine—breast cancer	0.00013	0.00015	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—breast cancer	0.00013	0.00015	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—breast cancer	0.00013	0.00015	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—breast cancer	0.00013	0.00015	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—breast cancer	0.00013	0.00015	CcSEcCtD
Pamidronate—FDPS—Metabolism—CYP17A1—breast cancer	0.00013	0.00301	CbGpPWpGaD
Pamidronate—Agitation—Epirubicin—breast cancer	0.000129	0.000149	CcSEcCtD
Pamidronate—FDPS—Metabolism—ENO1—breast cancer	0.000129	0.00298	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PTGS1—breast cancer	0.000129	0.00298	CbGpPWpGaD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000128	0.00297	CbGpPWpGaD
Pamidronate—Myalgia—Methotrexate—breast cancer	0.000128	0.000147	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—breast cancer	0.000128	0.000147	CcSEcCtD
Pamidronate—Tension—Doxorubicin—breast cancer	0.000128	0.000147	CcSEcCtD
Pamidronate—Vomiting—Paclitaxel—breast cancer	0.000128	0.000147	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—breast cancer	0.000128	0.000147	CcSEcCtD
Pamidronate—Malaise—Epirubicin—breast cancer	0.000127	0.000146	CcSEcCtD
Pamidronate—Rash—Paclitaxel—breast cancer	0.000127	0.000146	CcSEcCtD
Pamidronate—Dermatitis—Paclitaxel—breast cancer	0.000127	0.000146	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000126	0.00293	CbGpPWpGaD
Pamidronate—Discomfort—Methotrexate—breast cancer	0.000126	0.000146	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—breast cancer	0.000126	0.000146	CcSEcCtD
Pamidronate—Syncope—Epirubicin—breast cancer	0.000126	0.000145	CcSEcCtD
Pamidronate—FDPS—Metabolism—CYP2D6—breast cancer	0.000126	0.00292	CbGpPWpGaD
Pamidronate—Leukopenia—Epirubicin—breast cancer	0.000126	0.000145	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—breast cancer	0.000126	0.000145	CcSEcCtD
Pamidronate—Headache—Paclitaxel—breast cancer	0.000126	0.000145	CcSEcCtD
Pamidronate—Hypersensitivity—Docetaxel—breast cancer	0.000125	0.000144	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—breast cancer	0.000125	0.000144	CcSEcCtD
Pamidronate—FDPS—Metabolism—NCOA2—breast cancer	0.000124	0.00286	CbGpPWpGaD
Pamidronate—Confusional state—Methotrexate—breast cancer	0.000124	0.000142	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—breast cancer	0.000124	0.000142	CcSEcCtD
Pamidronate—Cough—Epirubicin—breast cancer	0.000123	0.000141	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—breast cancer	0.000123	0.000141	CcSEcCtD
Pamidronate—Asthenia—Docetaxel—breast cancer	0.000122	0.000141	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—breast cancer	0.000122	0.00014	CcSEcCtD
Pamidronate—Infection—Methotrexate—breast cancer	0.000122	0.00014	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—breast cancer	0.000121	0.00014	CcSEcCtD
Pamidronate—Hypersensitivity—Capecitabine—breast cancer	0.000121	0.00014	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—breast cancer	0.000121	0.000139	CcSEcCtD
Pamidronate—Pruritus—Docetaxel—breast cancer	0.00012	0.000139	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—breast cancer	0.00012	0.000139	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—breast cancer	0.00012	0.000139	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—breast cancer	0.00012	0.000138	CcSEcCtD
Pamidronate—FDPS—Metabolism—FASN—breast cancer	0.00012	0.00278	CbGpPWpGaD
Pamidronate—Arthralgia—Epirubicin—breast cancer	0.00012	0.000138	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—breast cancer	0.00012	0.000138	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—breast cancer	0.00012	0.000138	CcSEcCtD
Pamidronate—FDPS—Metabolism—BCHE—breast cancer	0.00012	0.00277	CbGpPWpGaD
Pamidronate—Anxiety—Epirubicin—breast cancer	0.000119	0.000137	CcSEcCtD
Pamidronate—Nausea—Paclitaxel—breast cancer	0.000119	0.000137	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—breast cancer	0.000119	0.000137	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—breast cancer	0.000118	0.000136	CcSEcCtD
Pamidronate—Asthenia—Capecitabine—breast cancer	0.000118	0.000136	CcSEcCtD
Pamidronate—FDPS—Metabolism—SLC5A5—breast cancer	0.000118	0.00273	CbGpPWpGaD
Pamidronate—Malaise—Doxorubicin—breast cancer	0.000117	0.000135	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—breast cancer	0.000117	0.000135	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—breast cancer	0.000117	0.000134	CcSEcCtD
Pamidronate—Pruritus—Capecitabine—breast cancer	0.000117	0.000134	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—breast cancer	0.000117	0.000134	CcSEcCtD
Pamidronate—Diarrhoea—Docetaxel—breast cancer	0.000117	0.000134	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—breast cancer	0.000116	0.000133	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—breast cancer	0.000115	0.000132	CcSEcCtD
Pamidronate—Oedema—Epirubicin—breast cancer	0.000115	0.000132	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—breast cancer	0.000115	0.000132	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—breast cancer	0.000114	0.000132	CcSEcCtD
Pamidronate—Infection—Epirubicin—breast cancer	0.000114	0.000131	CcSEcCtD
Pamidronate—FDPS—Metabolism—SLC2A1—breast cancer	0.000114	0.00264	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NQO1—breast cancer	0.000114	0.00264	CbGpPWpGaD
Pamidronate—Cough—Doxorubicin—breast cancer	0.000114	0.000131	CcSEcCtD
Pamidronate—Shock—Epirubicin—breast cancer	0.000113	0.00013	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—breast cancer	0.000113	0.00013	CcSEcCtD
Pamidronate—Diarrhoea—Capecitabine—breast cancer	0.000113	0.00013	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—breast cancer	0.000113	0.00013	CcSEcCtD
Pamidronate—Dizziness—Docetaxel—breast cancer	0.000113	0.00013	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—breast cancer	0.000112	0.000129	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—breast cancer	0.000112	0.000129	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—breast cancer	0.000112	0.000129	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000112	0.000129	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000112	0.00258	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP3A4—breast cancer	0.000111	0.00257	CbGpPWpGaD
Pamidronate—Hyperhidrosis—Epirubicin—breast cancer	0.000111	0.000128	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—breast cancer	0.000111	0.000128	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—breast cancer	0.000111	0.000128	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—breast cancer	0.000111	0.000128	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000111	0.00256	CbGpPWpGaD
Pamidronate—Anxiety—Doxorubicin—breast cancer	0.00011	0.000127	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—breast cancer	0.00011	0.000127	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—breast cancer	0.00011	0.000126	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—breast cancer	0.000109	0.000126	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—breast cancer	0.000109	0.000126	CcSEcCtD
Pamidronate—FDPS—Metabolism—CYP1B1—breast cancer	0.000109	0.00253	CbGpPWpGaD
Pamidronate—Somnolence—Methotrexate—breast cancer	0.000109	0.000126	CcSEcCtD
Pamidronate—Dizziness—Capecitabine—breast cancer	0.000109	0.000126	CcSEcCtD
Pamidronate—Vomiting—Docetaxel—breast cancer	0.000108	0.000125	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—breast cancer	0.000108	0.000124	CcSEcCtD
Pamidronate—Rash—Docetaxel—breast cancer	0.000107	0.000124	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—breast cancer	0.000107	0.000124	CcSEcCtD
Pamidronate—Dermatitis—Docetaxel—breast cancer	0.000107	0.000124	CcSEcCtD
Pamidronate—FDPS—Metabolism—HSP90AA1—breast cancer	0.000107	0.00248	CbGpPWpGaD
Pamidronate—Confusional state—Doxorubicin—breast cancer	0.000107	0.000123	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—breast cancer	0.000107	0.000123	CcSEcCtD
Pamidronate—Headache—Docetaxel—breast cancer	0.000107	0.000123	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—breast cancer	0.000106	0.000122	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—breast cancer	0.000106	0.000122	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—breast cancer	0.000106	0.000122	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—breast cancer	0.000106	0.000122	CcSEcCtD
Pamidronate—Infection—Doxorubicin—breast cancer	0.000106	0.000122	CcSEcCtD
Pamidronate—Pain—Methotrexate—breast cancer	0.000105	0.000121	CcSEcCtD
Pamidronate—Vomiting—Capecitabine—breast cancer	0.000105	0.000121	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000105	0.00012	CcSEcCtD
Pamidronate—Shock—Doxorubicin—breast cancer	0.000105	0.00012	CcSEcCtD
Pamidronate—FDPS—Metabolism—NCOA1—breast cancer	0.000104	0.00241	CbGpPWpGaD
Pamidronate—Nervous system disorder—Doxorubicin—breast cancer	0.000104	0.00012	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—breast cancer	0.000104	0.00012	CcSEcCtD
Pamidronate—Rash—Capecitabine—breast cancer	0.000104	0.00012	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—breast cancer	0.000104	0.00012	CcSEcCtD
Pamidronate—Dermatitis—Capecitabine—breast cancer	0.000104	0.00012	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—breast cancer	0.000104	0.000119	CcSEcCtD
Pamidronate—Headache—Capecitabine—breast cancer	0.000103	0.000119	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—breast cancer	0.000103	0.000119	CcSEcCtD
Pamidronate—FDPS—Metabolism—STK11—breast cancer	0.000103	0.00238	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP19A1—breast cancer	0.000103	0.00238	CbGpPWpGaD
Pamidronate—Hyperhidrosis—Doxorubicin—breast cancer	0.000103	0.000118	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—breast cancer	0.000102	0.000118	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—breast cancer	0.000102	0.000118	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—breast cancer	0.000101	0.000117	CcSEcCtD
Pamidronate—Nausea—Docetaxel—breast cancer	0.000101	0.000116	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—breast cancer	0.000101	0.000116	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—breast cancer	0.000101	0.000116	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—breast cancer	0.0001	0.000116	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—breast cancer	9.98e-05	0.000115	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—breast cancer	9.93e-05	0.000114	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—breast cancer	9.92e-05	0.000114	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—breast cancer	9.9e-05	0.000114	CcSEcCtD
Pamidronate—Pain—Epirubicin—breast cancer	9.82e-05	0.000113	CcSEcCtD
Pamidronate—Constipation—Epirubicin—breast cancer	9.82e-05	0.000113	CcSEcCtD
Pamidronate—Nausea—Capecitabine—breast cancer	9.79e-05	0.000113	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—breast cancer	9.7e-05	0.000112	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—breast cancer	9.7e-05	0.000112	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—breast cancer	9.68e-05	0.000111	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.65e-05	0.00223	CbGpPWpGaD
Pamidronate—Insomnia—Doxorubicin—breast cancer	9.61e-05	0.000111	CcSEcCtD
Pamidronate—FDPS—Metabolism—COMT—breast cancer	9.56e-05	0.00221	CbGpPWpGaD
Pamidronate—Paraesthesia—Doxorubicin—breast cancer	9.54e-05	0.00011	CcSEcCtD
Pamidronate—FDPS—Metabolism—GSTP1—breast cancer	9.51e-05	0.0022	CbGpPWpGaD
Pamidronate—Dyspnoea—Doxorubicin—breast cancer	9.47e-05	0.000109	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—breast cancer	9.46e-05	0.000109	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—breast cancer	9.45e-05	0.000109	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—breast cancer	9.39e-05	0.000108	CcSEcCtD
Pamidronate—FDPS—Metabolism—HMOX1—breast cancer	9.38e-05	0.00217	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ITPR1—breast cancer	9.36e-05	0.00217	CbGpPWpGaD
Pamidronate—Dyspepsia—Doxorubicin—breast cancer	9.35e-05	0.000108	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—breast cancer	9.24e-05	0.000106	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—breast cancer	9.17e-05	0.000106	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—breast cancer	9.16e-05	0.000105	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—breast cancer	9.09e-05	0.000105	CcSEcCtD
Pamidronate—Pain—Doxorubicin—breast cancer	9.09e-05	0.000105	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—breast cancer	9.08e-05	0.000105	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—breast cancer	9.08e-05	0.000105	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—breast cancer	9.04e-05	0.000104	CcSEcCtD
Pamidronate—FDPS—Metabolism—ABCB1—breast cancer	9e-05	0.00208	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—TYMS—breast cancer	8.84e-05	0.00205	CbGpPWpGaD
Pamidronate—Asthenia—Methotrexate—breast cancer	8.81e-05	0.000101	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—breast cancer	8.76e-05	0.000101	CcSEcCtD
Pamidronate—FDPS—Metabolism—GSTM1—breast cancer	8.74e-05	0.00202	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NCOR1—breast cancer	8.74e-05	0.00202	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PLA2G4A—breast cancer	8.74e-05	0.00202	CbGpPWpGaD
Pamidronate—Gastrointestinal pain—Doxorubicin—breast cancer	8.69e-05	0.0001	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—breast cancer	8.68e-05	0.0001	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—breast cancer	8.46e-05	9.74e-05	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—breast cancer	8.4e-05	9.67e-05	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—breast cancer	8.4e-05	9.67e-05	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—breast cancer	8.4e-05	9.67e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—GPX1—breast cancer	8.37e-05	0.00194	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—CYP1A1—breast cancer	8.29e-05	0.00192	CbGpPWpGaD
Pamidronate—Asthenia—Epirubicin—breast cancer	8.24e-05	9.49e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—ERCC2—breast cancer	8.22e-05	0.0019	CbGpPWpGaD
Pamidronate—Pruritus—Epirubicin—breast cancer	8.13e-05	9.36e-05	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—breast cancer	8.12e-05	9.34e-05	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—breast cancer	7.86e-05	9.05e-05	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—breast cancer	7.83e-05	9.02e-05	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—breast cancer	7.8e-05	8.99e-05	CcSEcCtD
Pamidronate—Rash—Methotrexate—breast cancer	7.74e-05	8.91e-05	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—breast cancer	7.73e-05	8.9e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—MTHFR—breast cancer	7.73e-05	0.00179	CbGpPWpGaD
Pamidronate—Headache—Methotrexate—breast cancer	7.69e-05	8.85e-05	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—breast cancer	7.62e-05	8.78e-05	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—breast cancer	7.59e-05	8.75e-05	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—breast cancer	7.52e-05	8.66e-05	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—breast cancer	7.3e-05	8.41e-05	CcSEcCtD
Pamidronate—Nausea—Methotrexate—breast cancer	7.29e-05	8.39e-05	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—breast cancer	7.27e-05	8.37e-05	CcSEcCtD
Pamidronate—Rash—Epirubicin—breast cancer	7.24e-05	8.34e-05	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—breast cancer	7.23e-05	8.33e-05	CcSEcCtD
Pamidronate—Headache—Epirubicin—breast cancer	7.19e-05	8.28e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—CAV1—breast cancer	7.13e-05	0.00165	CbGpPWpGaD
Pamidronate—Dizziness—Doxorubicin—breast cancer	7.03e-05	8.09e-05	CcSEcCtD
Pamidronate—Nausea—Epirubicin—breast cancer	6.82e-05	7.86e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.81e-05	0.00158	CbGpPWpGaD
Pamidronate—Vomiting—Doxorubicin—breast cancer	6.76e-05	7.78e-05	CcSEcCtD
Pamidronate—Rash—Doxorubicin—breast cancer	6.7e-05	7.72e-05	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—breast cancer	6.69e-05	7.71e-05	CcSEcCtD
Pamidronate—Headache—Doxorubicin—breast cancer	6.66e-05	7.67e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—PIK3CG—breast cancer	6.49e-05	0.0015	CbGpPWpGaD
Pamidronate—Nausea—Doxorubicin—breast cancer	6.31e-05	7.27e-05	CcSEcCtD
Pamidronate—FDPS—Metabolism—PIK3CD—breast cancer	5.71e-05	0.00132	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—ALB—breast cancer	5.63e-05	0.0013	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—NOS3—breast cancer	5.39e-05	0.00125	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PIK3CB—breast cancer	4.97e-05	0.00115	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PTGS2—breast cancer	4.93e-05	0.00114	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PTEN—breast cancer	4.3e-05	0.000995	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—PIK3CA—breast cancer	3.03e-05	0.000702	CbGpPWpGaD
Pamidronate—FDPS—Metabolism—AKT1—breast cancer	2.48e-05	0.000573	CbGpPWpGaD
